Victory Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,272
| Closed | -$221K | – | 2606 |
|
|
2020
Q2 | $221K | Sell |
12,272
-125,850
| -91% | -$2.27M | ﹤0.01% | 2272 |
|
|
2020
Q1 | $984K | Buy |
138,122
+64,511
| +88% | +$460K | ﹤0.01% | 1854 |
|
|
2019
Q4 | $1.76M | Buy |
73,611
+2,525
| +4% | +$60.3K | ﹤0.01% | 1556 |
|
|
2019
Q3 | $1.91M | Buy |
71,086
+69,547
| +4,519% | +$1.87M | ﹤0.01% | 1484 |
|
|
2019
Q2 | $42K | Hold |
1,539
| – | – | ﹤0.01% | 1756 |
|
|
2019
Q1 | $53K | Hold |
1,539
| – | – | ﹤0.01% | 1709 |
|
|
2018
Q4 | $30K | Sell |
1,539
-293
| -16% | -$5.71K | ﹤0.01% | 1729 |
|
|
2018
Q3 | $49K | Buy |
1,832
+241
| +15% | +$6.45K | ﹤0.01% | 1727 |
|
|
2018
Q2 | $60K | Hold |
1,591
| – | – | ﹤0.01% | 1747 |
|
|
2018
Q1 | $52K | Hold |
1,591
| – | – | ﹤0.01% | 1745 |
|
|
2017
Q4 | $77K | Buy |
1,591
+326
| +26% | +$15.8K | ﹤0.01% | 1721 |
|
|
2017
Q3 | $68K | Hold |
1,265
| – | – | ﹤0.01% | 1724 |
|
|
2017
Q2 | $71K | Buy |
1,265
+22
| +2% | +$1.24K | ﹤0.01% | 1712 |
|
|
2017
Q1 | $49K | Buy |
1,243
+194
| +18% | +$7.65K | ﹤0.01% | 1731 |
|
|
2016
Q4 | $24K | Buy |
1,049
+59
| +6% | +$1.35K | ﹤0.01% | 1746 |
|
|
2016
Q3 | $22K | Buy |
990
+66
| +7% | +$1.47K | ﹤0.01% | 1746 |
|
|
2016
Q2 | $22K | Buy |
924
+137
| +17% | +$3.26K | ﹤0.01% | 1594 |
|
|
2016
Q1 | $16K | Buy |
787
+63
| +9% | +$1.28K | ﹤0.01% | 1628 |
|
|
2015
Q4 | $37K | Buy |
724
+39
| +6% | +$1.99K | ﹤0.01% | 1608 |
|
|
2015
Q3 | $29K | Buy |
685
+51
| +8% | +$2.16K | ﹤0.01% | 1568 |
|
|
2015
Q2 | $29K | Buy |
+634
| New | +$29K | ﹤0.01% | 1575 |
|